Investing.com - Novartis ADR reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Novartis ADR announced earnings per share of $1.71 on revenue of $13.03B. Analysts polled by Investing.com anticipated EPS of $1.64 on revenue of $13.04B.
Novartis ADR shares are down 11.72% from the beginning of the year and are trading at $83.36 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
Novartis ADR follows other major Healthcare sector earnings this month
Novartis ADR's report follows an earnings beat by J&J on Tuesday, October 19, 2021, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Abbott Labs had beat expectations on Wednesday, October 20, 2021 with third quarter EPS of $1.4 on revenue of $10.93B, compared to forecast for EPS of $0.9449 on revenue of $9.56B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar